2Waldenmaier DS, Babarina A, Kischkel FC. Rapid in vitro chemosensitivity analysis of human colon tumor cell lines. Toxicol Applied Pharmacol. 2003,192: 237-245.
二级参考文献15
1O'Meara AT,Sevin BU. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer[J]. Gynecol Oncol,2001,83(2) :334-342.
2Sevin BU, Peng ZL, Perras JP, et al. Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing[J]. Gynecol Oncol, 1988,31 (1) : 191-204.
3Sevin BU, Perras JP, Averette HE, et al. Chemosensitivity testing in ovarian cancer[J]. Cancer, 1993,71 (4) : 1613-1620.
4Ng TY, Ngan HY, Cheng DK, et al. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer usign nonsurgical tumor cell samples[J]. Gynecol Oncol,2000,76(3) :405-408.
5Sevin BU, Perras JP. Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer[Jl. Am J Obstet Gynecol, 1997,176(4) : 759-766.
6Kurbacher CM, Cree IA, Bruckner HW, et al. Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer[J]. Anticancer Drugs, 1998,9(1) :51-57.
7Breidenbach M, Rein DT, Mallmann P, et al. Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatment[J]. Anticancer Drugs,2002,13(2):173-176.
8O'meara AT,Sevin BU. In vitro sensitivity of fresh ovarian carcinoma specimens to CPT-11(irinotecan) [J]. Gynecol Oncol, 1999,72(2) : 143-147.
9Neale MH, Charlton PA, Cree IA. Ex vivo activity of XR5000 against solid tumors [J]. Anticancer Drugs,2000,11(6) :471-478.
10Neale MH, Lamont A, Hindley A, et al. The ex vivo effect of high concentrations of doxorubicin on recurrent ovarian carcinoma[J]. Anticancer Drugs, 2000, 11 (10):865-871.
7Ekwall B,Sussman N. Intracellular ATP is the most accurate endpoint for in vitro prediction of cytotoxicity [J]. ATLA, 2000,28 : 201-234.
8Marcus Lehnhardt,Thomas Muehlberger,Cornelius Kuhnen,et al. Feasibility of chemosensitivity testing in soft tissue sarcomas [J ]. World Journal of Surgical Oncology, 2005,3(20): 1-12.
9Knight LA,Conroy M,Femando A,et al. Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay [ J ]. Anticancer Drugs, 2005,16 (9) : 969-976.
10Schmidt M, Bremer E, Hasenclever D,et al. Role of the progesterone receptor for paclitaxel resistance in primary breast cancer[J ]. Br J Cancer, 2007,96(2) : 241-247.
